Who owns ABEO?
Institutional ownership of Abeona Therapeutics Inc. from Form 13F, Q2 2026
127 institutional managers reported holding Abeona Therapeutics Inc. (ABEO) in Form 13F filings for Q2 2026, with 44,530,188 shares worth $275M. The largest reported holder was Nantahala Capital Management, LLC. Managers that filed both quarters added a net 4,996,327 shares (+12.6%). 31 opened new positions and 12 sold out.
- Funds holding
- 127
- Value held
- $275M
- New / sold out
- 31 / 12
- Net shares, same filers
- +12.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ABEO
Share of 13F holdings is each fund's shares as a share of the 44,530,188 ABEO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Nantahala Capital Management, LLC Added+$32.5M
- OneDigital Investment Advisors LLC New+$10.2M
- AWM Investment Company, Inc. Added+$4.2M
- Rubric Capital Management LP New+$3.8M
- Tudor Investment Corp Et Al New+$2.2M
- Barclays PLC Added+$2.0M
- Panagora Asset Management Inc Added+$1.3M
- Citadel Advisors LLC Added+$1.3M
- BlackRock, Inc. Added+$970K
- Diametric Capital, LP Added+$887K
Biggest sellers in Q2 2026
- Montanova Capital, LLC Trimmed-$13.4M
- 683 Capital Management, LLC Sold out-$3.4M
- Balyasny Asset Management L.P. Sold out-$2.6M
- Propel Bio Management, LLC Trimmed-$2.1M
- Tang Capital Management LLC Sold out-$1.8M
- Susquehanna International Group, LLP Trimmed-$1.5M
- Millennium Management LLC Trimmed-$1.3M
- JPMorgan Chase & Co Trimmed-$1.2M
- Stonepine Capital Management, LLC Trimmed-$1.2M
- Simplify Asset Management Inc. Trimmed-$1.0M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $69.2M and sold $34.6M; 43 added and 32 trimmed.
Schedule 13D and 13G filings on ABEO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16TPG GP A, LLC SCHEDULE 13G filed by Abeona Therapeutics Inc.Schedule 13G
- 2025-10-30VANGUARD GROUP INC SCHEDULE 13G filed by Abeona Therapeutics Inc.Schedule 13G
- 2025-10-06Nantahala Capital Partners Limited Partnership SCHEDULE 13G filed by Abeona Therapeutics Inc.Schedule 13G
- 2025-07-17BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
Questions about ABEO ownership
- Who owns ABEO stock?
- 127 institutional investment managers reported ABEO positions in their Form 13F filings for Q2 2026, holding 44,530,188 shares worth $275M in total. Nantahala Capital Management, LLC reported the largest position.
- Are funds buying or selling ABEO?
- In Q2 2026, 31 managers opened new ABEO positions, 43 added, 32 trimmed and 12 sold out. Managers that filed in both quarters added a net 4,996,327 shares.
- How current is this ABEO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ABEO by CUSIP. Options are left out. ABEO news and filings · ABEO insider trades · Top funds